Health systems across the United States are steering mergers and acquisitions toward outpatient assets, according to a Modern Healthcare analysis, a shift that marks the most visible change in hospital-sector dealmaking strategy in years.

The direction is unambiguous. Where hospital-on-hospital combinations once defined the market, executives now prioritise ambulatory surgery centres, physician practices, urgent care and other non-inpatient platforms. The finding, reported by Modern Healthcare, reflects a structural repositioning rather than a cyclical pause: systems are buying where care volume is migrating.

What does the shift mean for hospital dealmaking?

The logic is straightforward. Payers and regulators have made large hospital combinations harder to close, while patients increasingly receive surgical and diagnostic services outside the inpatient ward. Outpatient acquisitions give systems a route to grow revenue and capture patient flow without triggering the antitrust scrutiny that accompanies hospital consolidation.

For chief executives, the calculus is also operational. Outpatient assets typically carry lower fixed costs, faster build-out timelines and margin profiles that inpatient facilities struggle to match. Acquiring them extends a system's geographic footprint into suburban and retail settings where patients now expect to be treated.

Who is driving the change?

The pivot sits with the largest systems, which have the balance sheets to absorb multi-market outpatient platforms. For mid-sized regional operators, the same dynamics push toward narrower strategies: buy the ambulatory network, affiliate with the physician group, and reserve full hospital combinations for distressed situations.

Modern Healthcare's reporting frames the evolution as industry-wide rather than the product of a handful of transactions. Systems of different sizes are converging on the same conclusion — that the growth in care delivery lies outside the hospital walls.

What are the risks?

Outpatient deals carry their own constraints. Valuations for ambulatory surgery and physician assets have risen as private equity and payers compete for the same targets, compressing returns for hospital buyers. Integration is not trivial: physician employment models, service-line cannibalisation and payer contract renegotiation all complicate the post-deal picture.

Regulators, for now, apply a lighter hand to outpatient combinations than to hospital mergers. Buyers should not assume that persists indefinitely, as scrutiny of cross-market deals of every kind intensifies.

What comes next?

The trajectory points to continued divergence between two classes of hospital M&A: rare, large-scale hospital combinations pursued mostly by national operators, and a broad, steady flow of outpatient transactions executed across the rest of the sector. Systems that lack ambulatory strategies will find the inpatient route narrower, costlier and harder to defend to boards.

The deal market has already rendered its verdict. In healthcare consolidation, the growth story now lives outside the hospital.